Single-cell image analysis to assess ABC-transporter-mediated efflux in highly purified hematopoietic progenitors

Cytometry

Volumn 49, Issue 4, 2002, Pages 135-142

  Raaijmakers, H G P ^a   Van den Bosch, G ^a   Boezeman, J ^a   De Witte, T ^a   Raymakers, R A P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ABC transporter; CD34+CD38 ; Efflux; Epifluorescence microscopy; Hematopoietic stem cell; Multidrug resistance protein; P glycoprotein; Single cell image analysis

Indexed keywords

ABC TRANSPORTER; CALCEIN ACETOXYMETHYL ESTER; CD34 ANTIGEN; CD38 ANTIGEN; FLUORESCENT DYE; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; PROBENECID; RHODAMINE 123; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; EPIFLUORESCENCE MICROSCOPY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN TRANSPORT; PURIFICATION; REPRODUCIBILITY; SINGLE CELL IMAGE ANALYSIS; STEM CELL; VALIDATION PROCESS;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD38; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL ASSAY; FLOW CYTOMETRY; FLUORESCENT DYES; HEMATOPOIETIC STEM CELLS; HUMANS; IMAGE CYTOMETRY; IMAGE PROCESSING, COMPUTER-ASSISTED; JURKAT CELLS; MEMBRANE GLYCOPROTEINS; MICROSCOPY, FLUORESCENCE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MULTIPLE MYELOMA; P-GLYCOPROTEIN; PROBENECID; REPRODUCIBILITY OF RESULTS; VERAPAMIL;

EID: 0043239277     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.10157     Document Type: Article

References (40)

1. Bhatia M, Wang JC, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 1997;94:5320-5325.
2. Uchida N, Combs J, Chen S, Zanjani E, Hoffman R, Tsukamoto A. Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities. Blood 1996;88:1297-1305.
3. Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G, Grupp SA, Sieff CA, Mulligan RC, Johnson RP. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 1997;3:1337-1345.
4. Leemhuis T, Yoder MC, Grigsby S, Aguero B, Eder P, Srour EF. Isolation of primitive human bone marrow hematopoietic progenitor cells using Hoechst 33342 and Rhodamine 123. Exp Hematol 1996;24:1215-1224.
5. Mulder AH, Visser JWM. Separation and functional analysis of bone marrow cells separated by rhodamine-123 fluorescence. Exp Hematol 1987;15:99-104.
6. Udomsaki C, Eaves CJ, Sutherland HJ, Lansdorp PM. Separation of functionally distinct subpopulations of primitive human hematopoietic cells using rhodamine-123. Exp Hematol 1991;19:338-342.
7. Wulf GG, Wang RY, Kuehnle I, Weidner D, Marini F, Brenner MK, Andreeff M, Goodell MA. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood 2001;98:1166-1173.
8. Feuring-Buske M, Hogge DE. Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia. Blood 2001;97:3882-3889.
9. Chaudhary PM, Roninson IB. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991;66:85-94.
10. Smeets M, Raymakers R, Vierwinden G, Pennings A, van de LL, Wessels H, Boezeman J, de Witte T. A low but functionally significant MDR1 expression protects primitive haemopoietic progenitor cells from anthracycline toxicity. Br J Haematol 1997;96:346-355.
11. Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002;15:507-512.
12. Phillips RL, Ernst RE, Brunk B, Ivanova N, Mahan MA, Deanehan JK, Moore KA, Overton GC, Lemischka IR. The genetic program of hematopoietic stem cells. Science 2000;288:1635-1640.
13. Bailly JD, Muller C, Jaffrezou JP, Demur C, Gassar G, Bordier C, Laurent G. Lack of correlation between expression and function of Pgp in acute myeloid leukemia cells. Leukemia 1995;9:799.
14. Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Andreef M, Bates SE, Berard CE, Boyett JM, Brophy NA, Broxterman HJ, Chan HSL, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Kumar Srivastava D, Lehnert M, Leith CP, Paietts E, Pavelic ZP, Rimsza L, Roninson IB, Sikic BI, Twentyman PR, Warnke R, Weinstein R. Methods to detect P-glycoprotein-associated multidrug resisstance in patients' tumors: consensus recommendations. Cancer Res 1996;56:3010-3020.
15. Kessel D, Beck WT, Kukuruga D, Sculz V. Characterization of multidrug resistance by fluorescent dyes. Cancer Res 1991;51:4665-4670.
16. Homolya L, Holl Z, Germann UA, Pastan I, Gottesmann MM, Sarkadi B. Fluorescent cellular indicators are extruded by the multidrug resistance protein. J Biol Chem 1993;268:21493.
17. Petriz J, Garcia-Lopez J. Flow cytrometric analysis of P-glycoprotein function using rhodamine 123. Leukemia 1997;11:1124-1130.
18. Dalton WS, Durie BGM, Alberts DS, Gerlach JH, Cress AE. Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein. Cancer Res 1986;46:5125-5130.
19. Waite JH, Tanzer M.L. Polyphenolic substance of Mytilus edulis: novel adhesive containing L-dopa and hydroxyproline. Science 1981;212:1038-1040.
20. Zahn M, Renken J, Seeger S. Fluorimetric multiparameter cell assay at the single cell level fabricated by optical tweezers. FEBS Lett 1999;443:337-340.
21. Terstappen LWMM, Huang S, Safford M, Lansdorp PM, Loken MR. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood 1991;77:1218-1227.
22. Feller N, Kuiper CM, Lankelma J, Ruhdal JK, Scheper RJ, Pinedo HM, Broxterman HJ. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry. Br J Cancer 1995;72:543-549.
23. Laupeze B, Amiot L, Payen L, Drenou B, Grosset JM, Lehne G, Fauchet R, Fardel O. Multidrug resistance protein (MRP) activity in normal mature leukocytes and CD34-positive hematopoietic cells from peripheral blood. Life Sci 2001;68:1323-1331.
24. Gollapudi S, Kim CH, Tran BN, Sangha S, Gupta S. Probenecid reverses multidrug resistance in reistance-associated-protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells. Cancer Chemother Pharmacol 1997;40:150.
25. Prudencio C, Sansonetty F, Sousa MJ, Corte-Real M, Leao C. Rapid detection of efflux pumps and their relation with drug resistance in yeast cells. Cytometry 2000;39:26-35.
26. Bour-Dill C, Gramain MP, Merlin JL, Marchal S, Guillemin F. Determination of intracellular organelles implicated in daunorubicin cytoplasmic sequestration in multidrug-resistant MCF-7 cells using fluorescence microscopy image analysis. Cytometry 2000;39:16-25.
27. Lahmy S, Viallet P, Salmon JM. Is reduced accumulation of Hoechst 33342 in multidrug resistant cells related to P-glycoprotein activity? Cytometry 1995;19:126-133.
28. Vigo J, Salmon JM, Lahmy S, Viallet P. Fluorescent image cytometry: from qualitative to quantitative measurements. Anal Cell Pathol 1991;3:145-165.
29. Jericevic Z, Wiese B, Bryan J, Smith LC. Validation of an imaging system: steps to evaluate and validate a microscope imaging system for quantitative studies. Methods Cell Biol 1989;30:47-83.
30. Benson DM, Bryan J, Plant AL, Gotto AM Jr., Smith LC. Digital imaging fluorescence microscopy: spatial heterogeneity of photobleaching rate constants in individual cells. J Cell Biol 1985;100:1309-1323.
31. Chaudhary PM. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991;66:85-94.
32. Cohen RL, Muirhead KA, Gill JE, Waggoner AS, Horan PK. A cyanine dye distinguishes between cycling and non-cycling fibroblasts. Nature 1981;290:593.
33. Darzynkiewicz Z, Staiano-Coico L, Melamed MR. Increased mitochondrial uptake of rhodamine 123 during lymphocyte stimulation. Proc Natl Acad Sci USA 1981;78:2383.
34. Kim M, Cooper DD, Hayes SF, Spangrude GJ. Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood 1998;91:4106-4117.
35. Smeets ME, Raymakers RA, Vierwinden G, Pennings AH, Wessels H, de Witte T. Triggering noncycling hematopoietic progenitors and leukemic blasts to proliferate increases anthracycline retention and toxicity by downregulating multidrug resistance. Blood 1999;94:2414-2423.
36. Zijlmans JM, Visser JW, Kleiverda K, Kluin PM, Willemze R, Fibbe WE. Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability. Proc Natl Acad Sci USA 1995;92:8901-8905.
37. van der Kolk DM. Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells. Clin Cancer Res 1998;4:1727-1736.
38. Ueda K, Carderelli C, Gottesman MM, Pastan I. Expression of a full length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin and vinblastine. Proc Natl Acad Sci USA 1987;84:3004-3008.
39. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SP, Deeley RG. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994;54:357-361.
40. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-737.